Toronto - Delayed Quote CAD

Fennec Pharmaceuticals Inc. (FRX.TO)

9.04
+0.49
+(5.73%)
At close: May 8 at 12:11:23 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
47,538
47,538
21,252
1,535
0
Cost of Revenue
3,184
3,184
1,259
86
0
Gross Profit
44,354
44,354
19,993
1,449
0
Operating Expense
41,786
41,786
32,764
24,038
17,223
Operating Income
2,568
2,568
-12,771
-22,589
-17,223
Net Non Operating Interest Income Expense
-2,476
-2,476
-3,240
-932
-88
Other Income Expense
-163
-163
-34
-193
-35
Pretax Income
-71
-71
-16,045
-23,714
-17,346
Tax Provision
365
365
0
--
--
Net Income Common Stockholders
-436
-436
-16,045
-23,714
-17,346
Diluted NI Available to Com Stockholders
-436
-436
-16,045
-23,714
-17,346
Basic EPS
-0.02
--
-0.60
-0.90
-0.67
Diluted EPS
-0.02
--
-0.60
-0.90
-0.67
Basic Average Shares
27,294
--
26,574
26,275
26,006
Diluted Average Shares
27,294
--
26,574
26,275
26,006
Total Operating Income as Reported
2,568
2,568
-12,771
-22,589
-17,223
Total Expenses
44,970
44,970
34,023
24,124
17,223
Net Income from Continuing & Discontinued Operation
-436
-436
-16,045
-23,714
-17,346
Normalized Income
-307.23
-307.23
-16,011
-23,521
-17,311
Interest Income
1,682
1,682
441
195
54
Interest Expense
4,069
4,069
3,394
978
126
Net Interest Income
-2,476
-2,476
-3,240
-932
-88
EBIT
3,998
3,998
-12,651
-22,736
-17,220
EBITDA
4,798
4,798
-12,651
-22,736
-17,220
Reconciled Cost of Revenue
3,184
3,184
1,259
86
0
Reconciled Depreciation
800
800
0
149
16
Net Income from Continuing Operation Net Minority Interest
-436
-436
-16,045
-23,714
-17,346
Total Unusual Items Excluding Goodwill
-163
-163
-34
-193
-35
Total Unusual Items
-163
-163
-34
-193
-35
Normalized EBITDA
4,961
4,961
-12,617
-22,543
-17,185
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-34.23
-34.23
0
0
0
12/31/2021 - 6/12/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ZHCLF Zenith Capital Corp.
0.0001
0.00%
 
MBIO.CN MindBio Therapeutics Corp.
0.0050
-50.00%
 
EPRX.TO Eupraxia Pharmaceuticals Inc.
5.32
0.00%
 
MIR.V MedMira Inc.
0.0850
0.00%
 
BCT.TO BriaCell Therapeutics Corp.
4.4000
-3.30%
 
APS.TO Aptose Biosciences Inc.
2.2200
+3.26%
 
RVX.TO Resverlogix Corp.
0.0450
0.00%
 
NGEN.V NervGen Pharma Corp.
3.5900
0.00%
 
ZBIO Zenas BioPharma, Inc.
9.29
+6.54%
 
SVA.TO Sernova Biotherapeutics Inc
0.2000
-2.44%